Butler John P. 4
4 · Akebia Therapeutics, Inc. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Akebia (AKBA) CEO John Butler Sells Shares, Receives Award
What Happened John P. Butler, CEO, President and a director of Akebia Therapeutics (AKBA), reported multiple transactions on Feb 2, 2026. He disposed of a total of 341,305 shares in open-market or issuer sales at $1.39 per share for aggregate proceeds of $474,413. At the same time he acquired 175,250 shares at $1.41 per share (value $247,103) on settlement of vested performance-based awards. Net effect: Butler sold 166,055 more shares than he acquired, producing net cash proceeds of $227,310.
Key Details
- Transaction date: February 2, 2026; Form filed Feb 4, 2026 (timely).
- Sales: 46,660; 96,065; 114,891; and 83,689 shares — all at $1.39 per share — total sold = 341,305 shares for $474,413.
- Acquisition: 175,250 shares at $1.41 per share = $247,103 (settlement of performance stock units).
- Net: Sold 166,055 more shares than acquired; net cash received ≈ $227,310.
- Footnotes / reasons:
- Several sales were automatic issuer “sell-to-cover” transactions to satisfy tax-withholding on vested restricted stock units (RSUs) and performance stock units (PSUs).
- One sale was executed under a Rule 10b5-1 trading plan.
- The acquired shares reflect PSUs that vested after the company certified a stock-price performance condition.
- Shares owned after the transactions: not specified in the provided filing excerpt.
Context
- The acquisition was settlement of vested performance-based restricted stock units (PSUs) after a performance hurdle was certified; some of the newly vested shares were sold automatically to cover taxes. Sales executed under a 10b5-1 plan or for tax withholding are generally routine and don’t necessarily indicate a change in an insider’s view of the company.
Insider Transaction Report
Form 4
Butler John P.
DirectorCEO and President
Transactions
- Sale
Common Stock
[F1][F2]2026-02-02$1.39/sh−46,660$64,857→ 3,417,189 total - Sale
Common Stock
[F2][F3]2026-02-02$1.39/sh−96,065$133,530→ 3,321,124 total - Sale
Common Stock
[F2][F4]2026-02-02$1.39/sh−114,891$159,698→ 3,206,233 total - Award
Common Stock
[F5]2026-02-02$1.41/sh+175,250$247,103→ 3,381,483 total - Sale
Common Stock
[F2][F6]2026-02-02$1.39/sh−83,689$116,328→ 3,297,794 total
Holdings
- 159,928(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
- [F3]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.
- [F4]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025.
- [F5]As reported in February 2025, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2023 Stock Incentive Plan, as amended. Each PSU right represents a contingent right to receive one share of the Issuer's common stock. One-half of the total number of shares of common stock underlying the PSUs vests on the later of (i) the first anniversary of the grant date and (ii) the date that the Compensation Committee certifies that the average closing price of the Issuer's common stock equals or exceeds $3.50 over a 30-day trading period (the "Stock Price Hurdle 1 Performance Condition"), subject to the reporting persons continuous employment through the applicable vesting date. In July2025, the Compensation Committee certified that the Stock Price Hurdle 1 Performance Condition was met during the performance period and therefore one-half of the PSUs vested on January 31, 2026.
- [F6]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's performance stock units granted on January 31, 2025.
Signature
/s/ Carolyn M. Rucci, attorney-in-fact for John P. Butler|2026-02-04